Log In
Print
BCIQ
Print
Print this Print this
 

Cotara (131I-chTNT-1/B)

  Manage Alerts
Collapse Summary General Information
Company Peregrine Pharmaceuticals Inc.
DescriptionRadioactive chimeric tumor necrosis therapy (TNT) mAb that binds a DNA/histone complex
Molecular Target DNA/histone complex
Mechanism of ActionRadiolabelled antibody
Latest Stage of DevelopmentPhase II
IndicationBrain cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today